Endo Can't Shake FTC Pay-For-Delay Suit, Judge Told
By Isaac Monterose · June 11, 2021, 9:19 PM EDT
The Federal Trade Commission fought a dismissal bid Friday in an antitrust suit related to an alleged 2017 "pay-for-delay" agreement over Endo Pharmaceuticals' Opana ER painkiller, saying the drugmaker couldn't have...
To view the full article, register now.